Company / Cash per Share
TELA Bio, Inc. Cash per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.29
FY2025
5-year range
$1.29 / $3.04
FY2021-FY2025
Trend
-40.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share has declined for 6 consecutive years, from $153.19 in FY2019 to $1.29 in FY2025.
Based on SEC 10-K filings.
1.29 in FY2025 with a 5-year CAGR of -20.1%.
Declined from $2.44 to $1.29 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -23.6%
- 5-Year CAGR
- -20.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- TELA Bio, Inc.'s cash per share has declined for 6 consecutive years.
- In FY2025, cash per share decreased 40.0% year-over-year.
- Peak cash per share was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score -0.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.29 | -40.0% |
| FY2024 | $2.15 | -11.8% |
| FY2023 | $2.44 | -15.7% |
| FY2022 | $2.89 | -5.0% |
| FY2021 | $3.04 | -23.4% |
| FY2020 | $3.97 | -97.4% |
| FY2019 | $153.19 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026